Medication-Assisted Treatment (MAT)
Medication-assisted treatment (MAT) is the clinical use of FDA-approved medications, combined with counseling and behavioral therapies, to treat substance use disorders — most commonly opioid and alcohol use disorders.
Updated
Medication-assisted treatment (MAT), sometimes referred to as medications for opioid use disorder (MOUD) when focused on opioids, pairs an FDA-approved medication with counseling and behavioral therapy to treat substance use disorders. The federal agency SAMHSA (the Substance Abuse and Mental Health Services Administration, part of HHS) describes MAT as a whole-patient approach in which the medication addresses the physiological aspects of a substance use disorder while the behavioral component supports recovery.
For billing purposes, MAT services often bundle several distinct elements that may be documented and reported separately: the medication itself (which may be dispensed or administered), the drug administration or dispensing service, and the counseling or therapy visits. How these components are coded and paid depends on the setting — for example, an opioid treatment program (OTP), an office-based practice, or a hospital outpatient department — and on the payer. Coding uses the standard maintained code sets (CPT/HCPCS maintained through the AMA and CMS, and diagnosis codes from the ICD-10-CM set), rather than a single universal MAT code.
Coverage and payment rules for MAT vary by program and payer. Medicare established a bundled payment approach for OTPs, and Medicaid coverage of MAT is administered by each state within federal requirements, so covered medications, provider types, and reimbursement structures differ from state to state. Because these rules change over time and by jurisdiction, the authoritative CMS and Medicaid sources should be consulted for current specifics rather than relying on a single stated figure or rule.
In practice
In a behavioral health billing context, correctly reporting MAT typically means distinguishing the medication component from the associated services. Medications used in MAT may be billed under drug/supply codes, while the office visit, drug administration, and counseling or psychotherapy are reported under their own service codes and supported by documentation. In an opioid treatment program setting, Medicare uses a bundled structure that packages multiple MAT components together, which changes how items are itemized compared with an office-based or outpatient setting.
Because MAT sits at the intersection of pharmacy, medical, and behavioral health benefits, claims commonly require attention to the site of service, the rendering provider's qualifications and any applicable enrollment or authorization requirements, and payer-specific coverage policies. Prior authorization, quantity limits, and covered medication lists are set by individual payers and, for Medicaid, by each state — so billing teams generally verify the current policy for the specific plan and program rather than assuming a uniform national rule.
Commonly confused with
- Detoxification (withdrawal management): Detox is the short-term, medically supervised management of acute withdrawal. MAT is an ongoing treatment approach that may continue long after any acute withdrawal period, and it is not limited to the detox phase.
- Opioid treatment program (OTP): An OTP is a type of accredited, certified facility that delivers MAT for opioid use disorder. MAT is the treatment approach; the OTP is one setting where it is provided, each with its own billing and payment rules.
- Psychotherapy / behavioral health counseling: Counseling and psychotherapy are one component of MAT, but on their own they do not include the FDA-approved medication element that defines MAT. They are frequently reported under their own service codes.